Who invested in Contineum Therapeutics?
Contineum Therapeutics's investors include Versant Ventures, Perceptive Advisors, Casdin Capital and Samsara BioCapital.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$99Mraised across 1 round since 2025, from 1 source
From Contineum Therapeutics's own website: 11 on the team.
Contineum Therapeutics's investors include Versant Ventures, Perceptive Advisors, Casdin Capital and Samsara BioCapital.
Contineum Therapeutics has raised $99M across 1 round since 2025.
Contineum Therapeutics's most recent round was an Undisclosed round of $99M in Dec 2025.
Its most recent round, $99M in Dec 2025, is also its largest on record.
Contineum Therapeutics's first round on record, in Dec 2025, was backed by Versant Ventures, Perceptive Advisors and Casdin Capital and 1 others.
Contineum Therapeutics's latest named round is an Undisclosed round, in Dec 2025.
Contineum Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.